Targeted therapies for heart failure with preserved ejection fraction 2026 Addressing the "stiff heart" syndrome with novel drug classes
For many years, patients with preserved ejection fraction—where the heart pumps okay but doesn't fill well—had very few treatment options. However, 2026 has seen a breakthrough in medications that focus on the "filling phase" of the cardiac cycle. New agents that target the cyclic GMP pathway are showing great promise in...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
